UK Markets closed

argenx SE (0QW0.IL)

IOB - IOB Delayed price. Currency in EUR
Add to watchlist
381.45-2.10 (-0.55%)
At close: 06:06PM GMT
Full screen
Previous close383.55
Open382.00
Bid362.40 x N/A
Ask400.50 x N/A
Day's range375.50 - 385.30
52-week range224.50 - 405.10
Volume20,494
Avg. volume32,356
Market cap19.65B
Beta (5Y monthly)0.80
PE ratio (TTM)N/A
EPS (TTM)-6.37
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Globe Newswire

    argenx Enters Into Agreement To Acquire Priority Review Voucher

    Amsterdam, the Netherlands – November 30, 2022 – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced an agreement to acquire a U.S. Food and Drug Administration (FDA) Priority Review Voucher (PRV) for $102 million. A PRV entitles the holder to FDA priority review of a single Biologics License Application (BLA), which reduces the target review period and may lead to an expedited appr

  • Globe Newswire

    argenx Announces U.S. FDA Acceptance of Biologics License Application for Subcutaneous Efgartigimod in Generalized Myasthenia Gravis with Priority Review

    - Prescription Drug User Fee Act (PDUFA) target action date is March 20, 2023 - Submission based on positive results from the Phase 3 bridging study demonstrating noninferior total IgG reduction at day 29 with subcutaneously (SC) administered efgartigimod compared to intravenous (IV) administration November 22, 2022 Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, to

  • Globe Newswire

    argenx to Present at Upcoming Investor Conferences

    November 7, 2022Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that members of management will participate in several upcoming investor conferences in November: Guggenheim Healthcare Talks 4th Annual Immunology and Neurology Day. Fireside chat on Monday, November 14, 2022 at 11:20 a.m. ET in New York, NY.Stifel 2022 Healthcare Conference. Fireside chat